The hidden scale-out problem behind CAR-T’s growth
Source ↗
👁 0
💬 0
CAR-T’s commercial challenge is making thousands of patient-specific manufacturing runs behave like one reliable system. "In vivo" production techniques could be one solution.
Comments (0)